LTI
AGN.PRA

Laffer Tengler Investments’s Allergan plc AGN.PRA Stock Holding History

Laffer Tengler Investments’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,875
Closed -$2.86M – 262
2017
Q4 		$2.86M Sell
4,875
-263
-5% -$170K 0.72% 32
2017
Q3 		$3.79M Sell
5,138
-26
-0.5% -$21.6K 1% 10
2017
Q2 		$4.47M Sell
5,164
-30
-0.6% -$25.1K 1.14% 6
2017
Q1 		$4.41M Buy
5,194
+98
+2% +$81.2K 1.16% 6
2016
Q4 		$3.89M Buy
5,096
+520
+11% +$393K 1.04% 10
2016
Q3 		$3.76M Buy
4,576
+9
+0.2% +$7.78K 1.04% 18
2016
Q2 		$3.8M Buy
4,567
+1,492
+49% +$1.25M 1.08% 18
2016
Q1 		$2.83M Buy
+3,075
New +$2.94M 0.77% 30
2015
Q4 		– Hold
0
– – – 21
2015
Q3 		– Sell
-1,406
Closed -$1.47M – 43
2015
Q2 		$1.47M Buy
+1,406
New +$1.47M 0.36% 159

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Laffer Tengler Investments's AGN.PRA Position: Q1 2018 in Review

Laffer Tengler Investments sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 4,875 shares — an estimated $2.86M sold.

Laffer Tengler Investments first reported a position in AGN.PRA in Q2 2015 and held it in 9 quarters. The position peaked at $4.47M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Laffer Tengler Investments reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Laffer Tengler Investments sold 4,875 Allergan plc shares in Q1 2018, an estimated $2.86M.
  • Laffer Tengler Investments first reported a position in Allergan plc in Q2 2015 and held it in 9 quarters.
  • Laffer Tengler Investments's Allergan plc position peaked at $4.47M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Laffer Tengler Investments's 13F filing for Q1 2018, filed 14 May 2018.